NO160619B - GAS-LEAVING BATH ADDITIVE. - Google Patents
GAS-LEAVING BATH ADDITIVE. Download PDFInfo
- Publication number
- NO160619B NO160619B NO840396A NO840396A NO160619B NO 160619 B NO160619 B NO 160619B NO 840396 A NO840396 A NO 840396A NO 840396 A NO840396 A NO 840396A NO 160619 B NO160619 B NO 160619B
- Authority
- NO
- Norway
- Prior art keywords
- gas
- bath
- sodium
- weight
- parts
- Prior art date
Links
- 239000000654 additive Substances 0.000 title claims description 42
- 230000000996 additive effect Effects 0.000 title claims description 28
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 12
- 150000007524 organic acids Chemical class 0.000 claims description 12
- ANBBXQWFNXMHLD-UHFFFAOYSA-N aluminum;sodium;oxygen(2-) Chemical compound [O-2].[O-2].[Na+].[Al+3] ANBBXQWFNXMHLD-UHFFFAOYSA-N 0.000 claims description 9
- 239000000395 magnesium oxide Substances 0.000 claims description 9
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 claims description 9
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 claims description 9
- 229910001388 sodium aluminate Inorganic materials 0.000 claims description 9
- 239000003381 stabilizer Substances 0.000 claims description 6
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 18
- 230000000694 effects Effects 0.000 description 16
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 15
- 239000007789 gas Substances 0.000 description 15
- 229910002092 carbon dioxide Inorganic materials 0.000 description 10
- 239000001569 carbon dioxide Substances 0.000 description 9
- 239000000975 dye Substances 0.000 description 9
- 239000002304 perfume Substances 0.000 description 9
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 7
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 6
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 5
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 235000015165 citric acid Nutrition 0.000 description 5
- 235000005985 organic acids Nutrition 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 4
- 230000002378 acidificating effect Effects 0.000 description 4
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 239000001530 fumaric acid Substances 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 230000003578 releasing effect Effects 0.000 description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 description 3
- 235000017550 sodium carbonate Nutrition 0.000 description 3
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 3
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000005001 laminate film Substances 0.000 description 2
- 239000010446 mirabilite Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000010943 off-gassing Methods 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 229910000031 sodium sesquicarbonate Inorganic materials 0.000 description 2
- 235000018341 sodium sesquicarbonate Nutrition 0.000 description 2
- 229940074404 sodium succinate Drugs 0.000 description 2
- ZDQYSKICYIVCPN-UHFFFAOYSA-L sodium succinate (anhydrous) Chemical compound [Na+].[Na+].[O-]C(=O)CCC([O-])=O ZDQYSKICYIVCPN-UHFFFAOYSA-L 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- WCTAGTRAWPDFQO-UHFFFAOYSA-K trisodium;hydrogen carbonate;carbonate Chemical compound [Na+].[Na+].[Na+].OC([O-])=O.[O-]C([O-])=O WCTAGTRAWPDFQO-UHFFFAOYSA-K 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- YSLIPUSJNFIFAB-UHFFFAOYSA-N 2-oxopyridine-1-carboxylic acid Chemical compound OC(=O)N1C=CC=CC1=O YSLIPUSJNFIFAB-UHFFFAOYSA-N 0.000 description 1
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 1
- 241000512259 Ascophyllum nodosum Species 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000001744 Sodium fumarate Substances 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 239000001099 ammonium carbonate Substances 0.000 description 1
- 235000012501 ammonium carbonate Nutrition 0.000 description 1
- 229940059913 ammonium carbonate Drugs 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- 150000003841 chloride salts Chemical class 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- MSJMDZAOKORVFC-SEPHDYHBSA-L disodium fumarate Chemical compound [Na+].[Na+].[O-]C(=O)\C=C\C([O-])=O MSJMDZAOKORVFC-SEPHDYHBSA-L 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000005022 packaging material Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 229940093956 potassium carbonate Drugs 0.000 description 1
- 235000011181 potassium carbonates Nutrition 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 229940086066 potassium hydrogencarbonate Drugs 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 229960003504 silicones Drugs 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 235000011182 sodium carbonates Nutrition 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 229940005573 sodium fumarate Drugs 0.000 description 1
- 235000019294 sodium fumarate Nutrition 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 229940080313 sodium starch Drugs 0.000 description 1
- RSIJVJUOQBWMIM-UHFFFAOYSA-L sodium sulfate decahydrate Chemical compound O.O.O.O.O.O.O.O.O.O.[Na+].[Na+].[O-]S([O-])(=O)=O RSIJVJUOQBWMIM-UHFFFAOYSA-L 0.000 description 1
- 239000004328 sodium tetraborate Substances 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 230000000304 vasodilatating effect Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
Landscapes
- Treating Waste Gases (AREA)
- Gas Separation By Absorption (AREA)
Description
Denne oppfinnelse angår gass-avgivende badtilsetnings-midler som er stabilt holdbare over lengre tid. This invention relates to gas-emitting bath additives which are stable and durable over a longer period of time.
Badtilsetninger fremstilles vanligvis av blandinger av uorganiske salter eller materialer såsom Glauber-salt, boraks, svovel, natriumklorid, karbonater og lignende, blandet med parfymer, fargestoffer, planteekstrakter, organiske syrer og lignende. Slike tilsetninger tjener til å bibringe et varmt bad behagelig duft og farge og gir også huden nytt liv, slik at blodsirkulasjonen og stoffskiftet forbedres. Blant disse badtilsetninger er det kjent gassavgivende badtilsetninger omfattende kombina-sjoner av karbonater og organiske syrer. Denne type gass-avgivende badtilsetning muliggjør utvikling eller avgivelse av karbondioksyd-gass i et varmt bad, slik at man kan slappe av og nyte badet som oppfriskende. Bath additives are usually made from mixtures of inorganic salts or materials such as Glauber's salt, borax, sulphur, sodium chloride, carbonates and the like, mixed with perfumes, dyes, plant extracts, organic acids and the like. Such additives serve to give a warm bath a pleasant scent and color and also give the skin new life, so that blood circulation and metabolism are improved. Among these bath additives are known gas-emitting bath additives comprising combinations of carbonates and organic acids. This type of gas-emitting bath additive enables the development or release of carbon dioxide gas in a hot bath, so that you can relax and enjoy the bath as refreshing.
Selv om vannfrie karbonater og vannfrie organiske syrer anvendes i disse gassavgivende badtilsetninger, er de imidler-tid så ustabile at de kan reagere med hverandre i nærvær av selv små mengder fuktighet eller vann.hvilket medfører dannelse av karbondioksyd på et uønsket tidspunkt. Endog når slike gassavgivende badtilsetninger er pakket i tette beholdere, vil beholderen med tiden utvides på grunn av virkningen av den dannede karbondioksyd-gass. Dette resul-terer i mindre godt utseende av beholderen og nedsettelse av den kommersielle verdi, med den derav følgende ulempe at en tilfredsstillende gassavgivende effekt ikke kan oppnåes på grunn av nedsatt gassavgivende evne. Although anhydrous carbonates and anhydrous organic acids are used in these gas-releasing bath additives, they are nevertheless so unstable that they can react with each other in the presence of even small amounts of moisture or water, resulting in the formation of carbon dioxide at an undesired time. Even when such gas-emitting bath additives are packed in tight containers, the container will expand over time due to the action of the carbon dioxide gas formed. This results in a less good appearance of the container and a reduction in its commercial value, with the consequent disadvantage that a satisfactory gas-releasing effect cannot be achieved due to reduced gas-releasing ability.
Med sikte på å eliminere disse ulemper er det, uten hell With the aim of eliminating these disadvantages it is, without success
i praksis, blitt gjort forsøk på å anvende fuktighets-absorberende midler, såsom vannfritt natriumsulfat, stivelse og lignende. in practice, attempts have been made to use moisture-absorbing agents, such as anhydrous sodium sulfate, starch and the like.
Som resultat av våre studier av gassavgivende badtilsetninger ble det nå funnet at anvendelse av magnesiumoksyd og/eller natriumaluminat fører til gassavgivende badtilsetninger som er stabile og lagringsdyktige. As a result of our studies of gas-emitting bath additives, it has now been found that the use of magnesium oxide and/or sodium aluminate leads to gas-emitting bath additives that are stable and storable.
Den foreliggende oppfinnelse angår et gassavgivende badtilsetningsmiddel som gir badet en pH på 5-7, inneholdende karbonat, organisk syre, et stabiliseringsmiddel og vanlig anvendte additiver, karakterisert ved at det som stabiliseringsmiddel inneholder 0,5-15 vekt% magnesiumoksyd og/eller natriumaluminat. The present invention relates to a gas-emitting bath additive which gives the bath a pH of 5-7, containing carbonate, organic acid, a stabilizer and commonly used additives, characterized in that the stabilizer contains 0.5-15% by weight of magnesium oxide and/or sodium aluminate.
De karbonater som anvendes i det gassavgivende badtilsetningsmiddel ifølge oppfinnelsen, innbefatter eksempelvis tørket natriumhydrogenkarbonat, natriumkarbonat, natrium-seskvikarbonat, kaliumkarbonat, kaliumhydrogenkarbonat, ammoniumkarbonat og lignende. Av disse foretrekkes natriumhydrogenkarbonat og natriumkarbonat. Innholdet av karbonatet er i området 5-80 vekt%, fortrinnsvis 10-50 vekt%, av den samlede vekt av midlet. The carbonates used in the gas-emitting bath additive according to the invention include, for example, dried sodium hydrogen carbonate, sodium carbonate, sodium sesquicarbonate, potassium carbonate, potassium hydrogen carbonate, ammonium carbonate and the like. Of these, sodium bicarbonate and sodium carbonate are preferred. The content of the carbonate is in the range 5-80% by weight, preferably 10-50% by weight, of the total weight of the agent.
De organiske syrer er eksempelvis tørket sitronsyre, vinsyre, eplesyre, malonsyre, pyridon-karboksylsyre, ravsyre, fumarsyre, fosforsyre, natriumcitrat, natriumsuccinat, natriumfumarat, natriumfosfat og lignende. Disse syrer anvendes hensiktsmessig i avhengighet av den effekt som ønskes av badtilsetningen. Mengden av organisk syre er i området 10-300 vekt%, fortrinnsvis 30-150 vekt%, av vekten av det karbonat som er til stede i badtilsetningsmidlet. The organic acids are, for example, dried citric acid, tartaric acid, malic acid, malonic acid, pyridone carboxylic acid, succinic acid, fumaric acid, phosphoric acid, sodium citrate, sodium succinate, sodium fumarate, sodium phosphate and the like. These acids are used appropriately depending on the desired effect of the bath additive. The amount of organic acid is in the range 10-300% by weight, preferably 30-150% by weight, of the weight of the carbonate present in the bath additive.
Når et badtilsetningsmiddel omfattende et karbonat og When a bath additive comprising a carbonate and
en organisk syre er blitt tilsatt et varmt bad, vil disse reagere med hverandre og danne karbondioksyd-gass. Virkningen av den dannede karbondioksyd-gass avhenger av det varme badets pH. Når et varmt bad er surt, vil karbondioksyd-gassen foreligge som C02-molekyler og oppvise en blodsirkulasjonsforbedrende virkning. I motsetning hertil vil et varmt bad som har en pH på alkalisk side, ikke utvikle den ovenfor nevnte virkning, fordi karbondioksyd-gass foreligger som CO^<2>- eller HC03~. Det følger herav at det er gunstig å regulere blandingsforholdet mellom karbonat og organisk syre på en slik måte at et varmt bad vil være svakt surt etter at den gassavgivende badtilsetning er tilsatt: eksempelvis vil eh vandig oppløsning av 0,01 vekt% an organic acid has been added to a hot bath, these will react with each other and form carbon dioxide gas. The effect of the carbon dioxide gas formed depends on the pH of the hot bath. When a warm bath is acidic, the carbon dioxide gas will be present as C02 molecules and exhibit a blood circulation-improving effect. In contrast, a warm bath that has a pH on the alkaline side will not develop the above-mentioned effect, because carbon dioxide gas is present as CO^<2>- or HC03~. It follows from this that it is beneficial to regulate the mixing ratio between carbonate and organic acid in such a way that a warm bath will be slightly acidic after the gas-emitting bath additive has been added: for example, an aqueous solution of 0.01% by weight
av badtilsetningen ha en pH på 5-7. Det svakt sure varme bad vil tilnærmet ha samme pH som huden og gir en gunstig of the bath additive have a pH of 5-7. The slightly acidic warm bath will have approximately the same pH as the skin and provides a beneficial effect
virkning på huden. For oppnåelse av svak surhet er innholdet av organiske syrer fortrinnsvis som følger: det er i området 20-150 vekt% basert på karbonat (beregnet som natriumhydrogenkarbonat) for ravsyre eller fumarsyre, i området 40-300 vekt% basert på karbonat for natriumsuccinat, og i området 30-250 vekt% basert på karbonat for natrium-furnarat. effect on the skin. To achieve weak acidity, the content of organic acids is preferably as follows: it is in the range of 20-150% by weight based on carbonate (calculated as sodium bicarbonate) for succinic acid or fumaric acid, in the range of 40-300% by weight based on carbonate for sodium succinate, and in the range 30-250% by weight based on carbonate for sodium furnarate.
I et tilfelle hvor badtilsetningsmidlet ifølge foreliggende oppfinnelse forventes å avgi eller utvikle karbondioksyd-gass uten noen forventet farmakologisk effekt, kan på den annen side de to ingredienser blandes slik at pH In a case where the bath additive according to the present invention is expected to emit or develop carbon dioxide gas without any expected pharmacological effect, on the other hand, the two ingredients can be mixed so that the pH
vil være i det nøytrale eller svakt alkaliske område. I dette tilfelle foretrekkes det at blandingsforholdet mellom organisk syre og karbonat er lavere enn i ovennevnte tilfelle. will be in the neutral or slightly alkaline range. In this case, it is preferred that the mixing ratio between organic acid and carbonate is lower than in the above-mentioned case.
Ved utførelse av oppfinnelsen blir magnesiumoksyd og/eller natriumaluminat som anvendes som stabiliseringsmiddel, anvendt i en mengde mellom 0,5 og 15 vekt%, fortrinnsvis 0,5-10 vekt%, basert på den samlede vekt av midlet. Mengder mindre enn 0,1 vekt% er utilfredsstillende når det gjelder stabiliseringseffekt, mens mengder over 15 vekt% er ugunstige fordi de medfører flere ulemper, eksempelvis blir det varme bad meget uklart, eller det dannes stoffer som flyter på badet, eller såpe skummer dårlig. When carrying out the invention, magnesium oxide and/or sodium aluminate, which is used as a stabilizing agent, is used in an amount between 0.5 and 15% by weight, preferably 0.5-10% by weight, based on the total weight of the agent. Amounts less than 0.1% by weight are unsatisfactory in terms of stabilization effect, while amounts above 15% by weight are unfavorable because they cause several disadvantages, for example the hot bath becomes very cloudy, or substances are formed that float in the bath, or soap foams poorly .
Det gassavgivende badtilsetningsmiddel ifølge oppfinnelsen kan ytterligere omfatte, foruten de oven- The gas-emitting bath additive according to the invention may further comprise, in addition to the above-
nevnte ingredienser, sulfater såsom natriumsulfat, magnesium-sulfat, sinksulfat og lignende, klorider såsom natriumklorid og lignende, hvorved det oppnåes effekter som fra varme kilder, såsom Glauber-salt-kilder, sulfat-kilder, salt-kilder og lignende. Mengdene av disse forbindelser er, i kombinasjon, i området 30-500 vekt%, fortrinnsvis 50-200 vekt%, av den samlede vekt av karbonat, organisk syre og stabiliseringsmiddel som anvendes. said ingredients, sulfates such as sodium sulfate, magnesium sulfate, zinc sulfate and the like, chlorides such as sodium chloride and the like, whereby effects are obtained as from hot springs, such as Glauber salt springs, sulfate springs, salt springs and the like. The amounts of these compounds are, in combination, in the range 30-500% by weight, preferably 50-200% by weight, of the total weight of carbonate, organic acid and stabilizer used.
Det gassavgivende badtilsetningsmiddel ifølge oppfinnelsen kan ytterligere.omfatte parfymer, fargestoffer og, om det ønskes, vitaminer, effektive bestanddeler fra varme kilder, proteinaser, tang- og tare-ekstrakter, natrium-alginat, lanolin, silikoner, amfotere aktive midler og The gas-emitting bath additive according to the invention can further comprise perfumes, dyes and, if desired, vitamins, effective ingredients from hot springs, proteinases, seaweed and kelp extracts, sodium alginate, lanolin, silicones, amphoteric active agents and
urensede droger eller ekstrakter derav. impure drugs or extracts thereof.
Det gassavgivende badtilsetningsmiddel kan fremstilles som pulver, granuler, krystaller, tabletter og lignende. The gas-emitting bath additive can be produced as powder, granules, crystals, tablets and the like.
Av disse er tabletter de mest foretrukne med hensyn til gassabsorpsjon*. For fremstillingen kan hvilke: som helst tilsetninger, bindemidler, oppløsende midler, smøremidler og lignende tilsettes som vanlig. Det fremstilte eller formede gassavgivende badtilsetningsmiddel kan pakkes i emballasje-materiale som i det vesentlige er ugjennom-trengelig for vann, eksempelvis i en aluminiumlaminat-film, for en enkelt anvendelse. Alternativt kan tilsetningsmidlet i sin helhet plasseres i en lukket beholder for kommersielle formål. Of these, tablets are the most preferred in terms of gas absorption*. For the preparation, any additives, binders, solvents, lubricants and the like can be added as usual. The manufactured or shaped gas-emitting bath additive can be packed in packaging material which is essentially impermeable to water, for example in an aluminum laminate film, for a single use. Alternatively, the additive can be placed in its entirety in a closed container for commercial purposes.
Som det vil fremgå av ovenstående, er det gassavgivende badtilsetningsmiddel ifølge oppfinnelsen stabilt over lengre tid og oppløses lett i et varmt bad og er således lett å håndtere. Det utvikler eller avgir dessuten gass i en hensiktsmessig grad slik at man slapper av i badet og føler.seg oppfrisket. Badtilsetningsmidlet som reguleres til å være svakt surt, har den virkning at det fremmer blodsirkulasjonen ved sin vasodilaterende effekt. As will be apparent from the above, the gas-emitting bath additive according to the invention is stable over a long period of time and dissolves easily in a warm bath and is thus easy to handle. It also develops or emits gas to an appropriate degree so that you relax in the bath and feel refreshed. The bath additive, which is regulated to be slightly acidic, has the effect of promoting blood circulation through its vasodilating effect.
De følgende eksempler, i hvilke de angitte deler er The following examples, in which the specified parts are
på vektbasis, vil ytterligere belyse oppfinnelsen. on a weight basis, will further illuminate the invention.
Eksempel 1: Example 1:
50 deler natriumhydrogenkarbonat, 50 deler sitronsyre, 50 parts sodium bicarbonate, 50 parts citric acid,
1 del magnesiumoksyd, 1 del av en parfyme, og en passende mengde av et fargestoff ble plassert i en pulverblander og blandet tilstrekkelig. Blandingen ble i en tabletterings-maskin formet til tabletter med en diameter på 3 cm og en tykkelse på 1 cm. Tablettene ble tett pakket i en aluminiumlaminat-film og oppbevart ved en temperatur på 40°C ved en relativ fuktighet på 75 % i 6 måneder. De pakkede 1 part of magnesium oxide, 1 part of a perfume, and an appropriate amount of a dye were placed in a powder mixer and mixed sufficiently. The mixture was formed in a tableting machine into tablets with a diameter of 3 cm and a thickness of 1 cm. The tablets were tightly packed in an aluminum laminate film and stored at a temperature of 40°C at a relative humidity of 75% for 6 months. They packed
tabletter undergikk ingen forandring. Når tablettene ble tilsatt et varmt bad, utviklet det gass i en hensiktsmessig grad og gav en lignende virkning som massasje på huden og virket oppfriskende. tablets underwent no change. When the tablets were added to a warm bath, it developed gas to an appropriate degree and gave a similar effect to a massage on the skin and had a refreshing effect.
Eksempel 2: Example 2:
70 deler natriumhydrogenkarbonat, 30 deler vinsyre, 70 parts sodium bicarbonate, 30 parts tartaric acid,
1 del magnesiumoksyd, 1 del av en parfyme og en passende mengde av et fargestoff ble plassert i en pulverblander og blandet tilstrekkelig for oppnåelse av et pulverformig, gassavgivende badtilsetningsmiddel. Dette pulver ble pakket på samme måte som i eksempel 1 og oppbevart ved en temperatur på 40°C ved en relativ fuktighet på 75 % i 6 måneder. Det pakkede pulver undergikk ingen forandring. Når pulveret ble tilsatt et varmt bad, fulgte en intens utvikling av bobler, hvilket gav en lignende virkning som massasje på huden og virket oppfriskende. 1 part of magnesium oxide, 1 part of a perfume and an appropriate amount of a dye were placed in a powder blender and mixed sufficiently to obtain a powdery, off-gassing bath additive. This powder was packed in the same manner as in Example 1 and stored at a temperature of 40°C at a relative humidity of 75% for 6 months. The packed powder did not undergo any change. When the powder was added to a warm bath, an intense development of bubbles followed, which gave a similar effect to a massage on the skin and had a refreshing effect.
Eksempel 3: Example 3:
70 deler natriumkarbonat, 30 deler sitronsyre, 5 deler 70 parts sodium carbonate, 30 parts citric acid, 5 parts
natriumaluminat, 2 deler av en parfyme og en passende mengde av et fargestoff ble anvendt og behandlet på samme måte som 1 eksempel 1, hvorved det ble oppnådd et pulverformig, gass-avgivende badtilsetningsmiddel. Dette hadde den samme lagringsstabilitet og de samme virkninger som i tilfellet ifølge eksempel 1. sodium aluminate, 2 parts of a perfume and an appropriate amount of a dye were used and treated in the same manner as 1 Example 1, whereby a powdery, gas-emitting bath additive was obtained. This had the same storage stability and the same effects as in the case according to example 1.
Eksempel 4: Example 4:
60 deler natrium-seskvikarbonat, 40 deler sitronsyre, 0,5 del natriumaluminat, 1 del av en parfyme og en passende mengde av et fargestoff ble anvendt og behandlet på samme måte som i eksempel 2, hvorved det ble oppnådd et pulverformig, gassavgivende badtilsetningsmiddel. Dette hadde den samme lagringsstabilitet og de samme virkninger som i tilfellet ifølge eksempel 1. 60 parts of sodium sesquicarbonate, 40 parts of citric acid, 0.5 part of sodium aluminate, 1 part of a perfume and an appropriate amount of a dye were used and processed in the same manner as in Example 2, whereby a powdery, gas-emitting bath additive was obtained. This had the same storage stability and the same effects as in the case according to example 1.
Eksempel 5: Example 5:
50 deler natriumhydrogenkarbonat, 55 deler sitronsyre, 50 parts sodium bicarbonate, 55 parts citric acid,
2 deler magnesiumoksyd, 1 del av en parfyme og en passende mengde av et fargestoff ble anvendt og behandlet på samme måte som i eksempel 1, hvorved det ble oppnådd tabletter av gassavgivende badtilsetningsmiddel. Tilsetningsmidlet hadde den samme lagringsstabilitet som i tilfellet ifølge eksempel 1. Når tablettene ble tilsatt et varmt bad, ble de funnet å utvikle gassbobler, hvilket hadde en lignende virkning som massasje på huden og stimulerte blodsirkulasjonen. En 0,01 vekt% vandig oppløsning av badtilsetningsmidlet viste en pH på 5,4. 2 parts of magnesium oxide, 1 part of a perfume and an appropriate amount of a dye were used and treated in the same manner as in Example 1, whereby tablets of gas-emitting bath additive were obtained. The additive had the same storage stability as in the case of Example 1. When the tablets were added to a warm bath, they were found to develop gas bubbles, which had a similar effect to massage on the skin and stimulated blood circulation. A 0.01% by weight aqueous solution of the bath additive showed a pH of 5.4.
Eksempel 6: Example 6:
30 deler natriumhydrogenkarbonat, 40 deler ravsyre, 25 deler natriumsulfat, 2 deler natriumaluminat, 1 del av en parfyme og en passende mengde av et fargestoff ble anvendt og behandlet på samme måte som i eksempel 1, hvorved det ble oppnådd et gassavgivende badtilsetningsmiddel i form av tabletter. Dette middel hadde den samme lagringsstabilitet som midlet i eksempel 1. Når tilsetningsmidlet ble tilsatt et varmt bad, ble dette omdannet til en slags karbonat- eller saltkake-kilde. En 0,01 vekt% vandig opp-løsning av det gassavgivende badtilsetningsmiddel hadde en pH på 6,5. 30 parts of sodium bicarbonate, 40 parts of succinic acid, 25 parts of sodium sulfate, 2 parts of sodium aluminate, 1 part of a perfume and an appropriate amount of a dye were used and treated in the same manner as in Example 1, whereby a gas-emitting bath additive was obtained in the form of pills. This agent had the same storage stability as the agent in example 1. When the additive was added to a hot bath, this was converted into a kind of carbonate or salt cake source. A 0.01% by weight aqueous solution of the outgassing bath additive had a pH of 6.5.
Eksempel 7: Example 7:
70 deler natriumhydrogenkarbonat, 30 deler fumarsyre, 2 deler magnesiumoksyd, 1 del natriumaluminat, 1 del av en parfyme, en passende mengde av et fargestoff og 0,5 del natrium-CMC ble anvendt og behandlet på samme måte som i eksempel 1, hvorved det ble oppnådd tabletter av gass-avgivende badtilsetningsmiddel. Dette middel hadde den samme lagringsstabilitet og de samme virkninger som i tilfellet ifølge eksempel 1. 70 parts of sodium bicarbonate, 30 parts of fumaric acid, 2 parts of magnesium oxide, 1 part of sodium aluminate, 1 part of a perfume, an appropriate amount of a dye and 0.5 part of sodium CMC were used and treated in the same manner as in Example 1, whereby the tablets of gas-emitting bath additive were obtained. This agent had the same storage stability and the same effects as in the case according to example 1.
Sammenligningseksempel: Comparison example:
Eksempler 1-6 ble gjentatt uten anvendelse av magnesiumoksyd eller natriumaluminat, hvorved gassavgivende bad-tilsetningsmidler ble fremstilt. Disse tilsetningsmidler ble oppbevart på samme måte som i de foregående eksempler, med det resultat at karbondioksyd-gass ble utviklet på 3 dager til 2 uker, og emballasje-beholderne var alle utvidet i betydelig grad. Examples 1-6 were repeated without the use of magnesium oxide or sodium aluminate, whereby gas-emitting bath additives were produced. These additives were stored in the same manner as in the previous examples, with the result that carbon dioxide gas was evolved in 3 days to 2 weeks, and the packaging containers were all significantly expanded.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NO840396A NO160619C (en) | 1984-02-02 | 1984-02-02 | GAS-LEAVING BATH ADDITIVE. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NO840396A NO160619C (en) | 1984-02-02 | 1984-02-02 | GAS-LEAVING BATH ADDITIVE. |
Publications (3)
Publication Number | Publication Date |
---|---|
NO840396L NO840396L (en) | 1985-08-05 |
NO160619B true NO160619B (en) | 1989-01-30 |
NO160619C NO160619C (en) | 1989-05-10 |
Family
ID=19887467
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO840396A NO160619C (en) | 1984-02-02 | 1984-02-02 | GAS-LEAVING BATH ADDITIVE. |
Country Status (1)
Country | Link |
---|---|
NO (1) | NO160619C (en) |
-
1984
- 1984-02-02 NO NO840396A patent/NO160619C/en unknown
Also Published As
Publication number | Publication date |
---|---|
NO840396L (en) | 1985-08-05 |
NO160619C (en) | 1989-05-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1217146A (en) | Gas-emitting bath additive composition | |
US4689169A (en) | Dry compositions for the production of chlorine dioxide | |
US2035267A (en) | Effervescent sodium perborate | |
KR101477311B1 (en) | Composition for stabilizing chlorine dioxide | |
WO2008041045A1 (en) | A multi chamber container for the production and dispensing of carbon dioxide foam, process for production and use of said foam | |
US5908864A (en) | Creatine gel | |
JPH03227910A (en) | Method and composition for preparing foaming aqueous solution having softening action on nail cuticula and corresponding cosmetic treatment | |
MY109531A (en) | Effervescent antacid | |
EP0418892B1 (en) | Bathing preparation | |
CN109645113A (en) | A kind of fresh-keeping gel of chlorine dioxide slow-release and its preparation method and application | |
US6197215B1 (en) | Composition for generating chlorine dioxide | |
CN107822034A (en) | A kind of Chilled Mango Sago Cream with Pomelo compound nectar and preparation method thereof | |
EP0150250B1 (en) | Gas-emitting bath additive composition | |
NO160619B (en) | GAS-LEAVING BATH ADDITIVE. | |
US3576644A (en) | Dry alcoholic beverage forming compound | |
JPH01254619A (en) | Bathing agent | |
JPS61243014A (en) | Foaming bath agent | |
US1339783A (en) | Cleansing and sterilizing preparation | |
JPS6245516A (en) | Foamable bathing agent | |
KR900007309B1 (en) | Effervescent cleaner for bath | |
US2060926A (en) | Egg treatment process and product | |
Davidson et al. | Salt crystals-science behind the magic | |
US2107559A (en) | Carbonated beverage | |
CN105941609A (en) | Preservative for preservation of mango | |
JPS6313403B2 (en) |